Alcohol accounts for significant death and disability worldwide. According to the World Health Organisation (WHO), nearly one-quarter of deaths among those aged 20-39 can be attributed to alcohol, researchers said.
"The idea is that a small reduction in alcohol - such as beer with four per cent ethanol content versus six per cent - would reduce alcohol intake per drinker even if the same overall amount of beverage is consumed," said Jurgen Rehm, from the Centre for Addiction and Mental Health in Canada.
This could reduce immediate harms such as injuries or accidents, as well as alcohol-related chronic diseases that develop over time, such as liver cirrhosis or cancer.
A key concern is that drinkers would notice the difference in alcohol content, and consume more to compensate or switch to other beverages with more alcohol.
"We know from experiments that consumers can't distinguish between beers of different strengths," said Rehm.
In one study set at three fraternity parties, the amount party-goers drank did not differ with weaker versus stronger drinks.
In both studies, participants had a significantly lower blood alcohol concentration with lower-alcohol drinks.
The researchers also found some studies on the broader, societal impact.
The Northern Territories of Australia levied a tax on alcohol with more than three per cent ethanol, which led to greater availability of lower-strength beer.
This policy change resulted in fewer alcohol-related deaths, but also took place in combination with educational efforts, greater controls on availability and new treatment services.
The drawback is that not only does it require drinkers to choose this option, but there is limited evidence that it affects drinking levels or alcohol-related harms.
Whether lower-strength alcohol can reduce the burden of alcohol harms will depend on how any measure is implemented and evaluated, researchers said.
However, the evidence suggests it is worth considering as a "win-win" for public health efforts and alcohol producers.
The study was published in the journal Lancet Gastroenterology and Hepatology.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
